NCT02119234View on ClinicalTrials.gov

Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
COPD
Interventions
DRUG

Beclometasone/formoterol/glycopyrrolate

DRUG

Placebo

Trial Locations (1)

90-153

Medical University in Lodz, Lodz

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02119234 - Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients | Biotech Hunter | Biotech Hunter